RallyBio will lay off 40% of its New Haven workforce as it shifts focus to new drug programs and streamlines operations.

While venture funding is rising, federal policy upheaval may affect women’s health research more acutely than other fields, ...

Researchers developed FaceAge, an AI tool that calculate's a patient biological age from a photo of their face. In a new study, the researchers tied FaceAge results to health outcomes in people with ...

When journalist Amanda Hess was 7 months pregnant, a routine ultrasound revealed that her baby appeared to be sticking out ...

This 'treatable fetal ... Apr. 3, 2025 — Early administration of the drug Fosdenopterin/rcPMP improves the chances of survival of infants with MoCD type A and promotes the development of ...

Jean-Jacques Bienaimé According to Bienaimé, a “convergence of information technology and biotechnology” is ... adding a new programme in immunology. The new phase will be focused on drug ...

There’s a new biotech on the scene after MoonLake Immunotherapeutics ... Spike Loy, managing director of BVF Partners said MoonLake's "expert immunology team...has the depth and breadth of ...

Researchers looking to study the social ramifications of mass traumas must not overlook the histories of affected communities in the search for healing.